Genmab Patents – Key Insights and Stats

Genmab has a total of 1776 patents globally, out of which 555 have been granted. Of these 1776 patents, more than 77% patents are active. The USA is where Genmab has filed the maximum number of patents, followed by Japan and European Countries, it has generated an annual revenue of $1.34 billion in the year 2021. Parallelly, Denmark seems to be the main focused R&D centre of Genmab.

Genmab was founded in the year 1999 Florian Schönharting and Lisa Drakeman. Company is a Danish biotechnology company. As of July 2022, Genmab has a market cap of $22.35 Billion.

Do read about some of the most popular patents of Genmab which have been covered by us in this article and also you can find Genmab patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Genmab patent portfolio.

How many patents does the founder and the CEO of Genmab have?

The founders, Florian Schönharting and Lisa Drakeman, have 31 and 0 patents respectively. The CEO, Jan van de Winkel, has 90 patents.

How many patents does Genmab have?

Genmab has a total of 1776 patents globally. These patents belong to 375 unique patent families. Out of 1776 patents, 1372 patents are active.

How Many Patents did Genmab File Every Year?

Genmab Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantGenmab Applications FiledGenmab Patents Granted
201111616
201210727
20136313
20147529
20156132
201615330
201710757
20188939
201924292
202012190
202111248
20222028

How many Genmab patents are Alive/Dead?

Genmab Patent Portfolio

How Many Patents did Genmab File in Different Countries?

Genmab Worldwide Patent Filing

Countries in which Genmab Filed Patents

CountryPatents
United States Of America229
Japan208
Europe125
Australia107
Korea (South)96
Hong Kong (S.A.R.)93
Singapore69
Canada68
India66
Israel62
Germany50
Brazil47
Mexico46
China43
New Zealand40
Eurasia34
Spain30
Denmark22
Hungary21
Poland20
Portugal20
Lithuania18
Slovenia16
Serbia13
South Africa12
Montenegro11
Croatia10
Taiwan9
Albania9
Indonesia7
Austria6
Philippines6
Cyprus6
Ukraine5
Russia5
Argentina4
Turkey3
Peru3
Costa Rica2
Luxembourg2
Norway2
Viet Nam2
Panama2
Chile2
Malaysia2
Czech Republic1
Dominican Republic1
United Kingdom1

Where are Research Centres of Genmab Patents Located?

R&D Centres of Genmab

10 Best Genmab Patents

US7153507B2 is the most popular patent in the Genmab portfolio. It has received 451 citations so far from companies like Amgen, Abbvie Biotechnology, and Innate Pharma.

Below is the list of 10 most cited patents of Genmab:

Publication NumberCitation Count
US7153507B2451
WO2008145142A1285
US7247301B2239
US20040255137A1159
US20060161789A1127
WO2011154453A1119
US7829673B2110
WO2012143523A1109
WO2004058797A2108
WO2011147986A1105

EXCLUSIVE INSIGHTS COMING SOON!

What are Genmab’s key innovation segments?

What Technologies are Covered by Genmab?

The chart below distributes patents filed by Genmab in different countries on the basis of the technology protected in patents. It also represents the markets where Genmab thinks it’s important to protect particular technology inventions.

R&D Focus: How Genmab’s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Genmab?

Updated on July 19, 2022

Was this article helpful?

Leave a Comment